DOD Biotech PCL (BKK:DOD-F) Total Current Assets : ฿350.5 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is DOD Biotech PCL Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. DOD Biotech PCL's total current assets for the quarter that ended in Mar. 2024 was ฿350.5 Mil.

DOD Biotech PCL Total Current Assets Historical Data

The historical data trend for DOD Biotech PCL's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DOD Biotech PCL Total Current Assets Chart

DOD Biotech PCL Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Current Assets

Get a 7-Day Free Trial

440.17

673.42

626.00

197.13

371.96

DOD Biotech PCL Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Current Assets	Get a 7-Day Free Trial															280.95	321.33	352.28	371.96	350.52

DOD Biotech PCL Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

DOD Biotech PCL's Total Current Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	67.989	+	111.643	+	150.403	+	41.921
	=	372.0

DOD Biotech PCL's Total Current Assets for the quarter that ended in Mar. 2024 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	66.781	+	100.406	+	144.758	+	38.574
	=	350.5

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

DOD Biotech PCL (BKK:DOD-F) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

DOD Biotech PCL's Liquidation Value for the quarter that ended in Mar. 2024 is

	Liquidation value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	66.781	-	342.754	+	0.75 * 100.406	+	0.5 * 144.758
=	-128.3

DOD Biotech PCL Total Current Assets Related Terms

Thank you for viewing the detailed overview of DOD Biotech PCL's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

DOD Biotech PCL (BKK:DOD-F) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » DOD Biotech PCL (BKK:DOD-F) » Definitions » Total Current Assets

Comparable Companies

Traded in Other Exchanges

DOD:Thailand

Address

No.111, Moo 2, Tumbol Taa jeen, Amphor Muengsamutsakhon, Samut Sakhon, THA, 74000

Website

https://www.dodbiotech.com

DOD Biotech PCL is engaged in the business of food supplements and health drinks of all kinds. The company offers Skincare products, Dietary supplements, Healthy supplements, and Own branded products. The majority of the company's revenue is derived from the supplementary business segment within Thailand. The segments of the group are Supplementary business, Manufacturing cosmetic and Network marketing, Manufacturing Extraction business, and others, of which a majority of revenue is derived from the Supplementary business segment.

DOD Biotech PCL (BKK:DOD-F) Headlines

No Headlines